1-(Piperidin-1-yl)-2-sulfanylethan-1-one | 1005-05-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-(Piperidin-1-yl)-2-sulfanylethan-1-one
• 英文别名: 1-piperidin-1-yl-2-sulfanylethanone
• CAS: 1005-05-6
• 化学式: C₇H₁₃NOS
• 分子量: 159.25
• InChiKey: GVEPWYLNBKUPDJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Ion Channel Modulators
  申请人：Zelle Robert

  公开号：US20070281937A1

  公开（公告）日：2007-12-06

  The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.

  这项发明涉及化合物、包含这些化合物的组合物，以及使用这些化合物和化合物组合物的方法。本文描述的化合物、组合物和方法可用于治疗调节离子通道功能，以及治疗疾病和疾病症状，特别是那些由特定钙通道亚型靶点介导的疾病。
• BIGUANIDE COMPOUNDS AND USE THEREOF
  申请人：HANALL BIOPHARMA CO., LTD.

  公开号：US20150126518A1

  公开（公告）日：2015-05-07

  The present invention relates to biguanide compounds and use thereof, more particularly, to biguanide derivatives exhibiting excellent effects for inhibition of cancer cell proliferation and inhibition of cancer metastasis and recurrence, a method for preparing the same, a pharmaceutical composition containing the same as an active ingredient, and a method of prevention or treatment of cancer comprising the step of administering an effective amount of the composition to a subject in need thereof.

  本发明涉及双胍类化合物及其使用，更具体地涉及表现出对抑制癌细胞增殖、抑制癌转移和复发具有优异效果的双胍衍生物，以及制备该化合物的方法、含有该化合物作为活性成分的药物组合物，以及包括向需要的受试者施用所述组合物的有效量的步骤的癌症预防或治疗方法。
• ION CHANNEL MODULATORS
  申请人：Zelle Robert

  公开号：US20080090891A1

  公开（公告）日：2008-04-17

  The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.

  本发明涉及化合物、含有该化合物的组合物以及使用该化合物和组合物的方法。本文所描述的化合物、组合物和方法可用于治疗离子通道功能的治疗调节，以及治疗疾病和疾病症状，特别是那些由特定钙通道亚型靶点介导的疾病和疾病症状。
• Biguanide compounds and use thereof
  申请人：IMMUNOMET THERAPEUTICS INC.

  公开号：US10221190B2

  公开（公告）日：2019-03-05

  The present invention relates to biguanide compounds and use thereof, more particularly, to biguanide derivatives exhibiting excellent effects for inhibition of cancer cell proliferation and inhibition of cancer metastasis and recurrence, a method for preparing the same, a pharmaceutical composition containing the same as an active ingredient, and a method of prevention or treatment of cancer comprising the step of administering an effective amount of the composition to a subject in need thereof.

  本发明涉及双胍类化合物及其用途，更具体地说，涉及在抑制癌细胞增殖、抑制癌症转移和复发方面具有卓越效果的双胍类衍生物、制备方法、含有双胍类衍生物作为活性成分的药物组合物，以及预防或治疗癌症的方法，该方法包括向有需要的受试者施用有效量的组合物的步骤。
• FABP4 as a therapeutic target in skin diseases
  申请人：TICURE LTD.

  公开号：US11229624B2

  公开（公告）日：2022-01-25

  Provided are methods of regulating proliferation and/or differentiation of keratinocytes and immune cells, more specifically to methods of treating pathologies characterized by hyperproliferative keratinocytes or inflammatory skin diseases by administration of FABP4-inhibitor.

  本发明提供了调节角质细胞和免疫细胞增殖和/或分化的方法，更具体地说，提供了通过服用 FABP4 抑制剂治疗以角质细胞过度增殖或炎症性皮肤病为特征的病症的方法。